MAPT and neurodegenerative disease: The created system is characterized by sufficient sensitivity and specificity to routine methods.22 Being a powerful method with few sample treatment requirements, high sensitivity, and immediate identifying capability, mass spectrometry was applied for determining tau protein as a critical neurodegenerative disease biomarker.23 In general, routine methods for diagnosing tau protein have certain advantages and disadvantages, as illustrated in Table 1.